Newsroom

Welcome to Blood Cancer United Newsroom

Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.

News September 13, 2022

Light The Night Events to Illuminate Skies Across North America and Bring Light to the Darkness of Cancer

News August 31, 2022

When Someone is Diagnosed with Blood Cancer, Every Minute Matters

News August 29, 2022

FDA Approves New Treatment for Children and Young Adults with Chronic Graft versus Host Disease

This week marked another milestone for the treatment of graft versus host disease in children. The U.S. Food and Drug Administration (FDA) approved ib…

Research August 17, 2022

Apply to the Academic Clinical Trials Program

Enhancing the development and implementation of academic investigator initiated clinical trials (IIT) in the hematological malignancy space. Go dir…

News August 7, 2022

Cancer Patients Cheer Senate Passage of Landmark Health Reforms

“We’re elated for—and alongside—cancer patients who have been advocating for these reforms for years,” said Gwen Nichols, M.D., LLS Chief Medical Offi…

August 1, 2022

LLS Community Guide: Unsubscribe from Email Notifications/Deactivate Account

News July 28, 2022

LLS Appoints Chief People Officer

Patient Education Webcasts July 27, 2022

Coffee With LLS: Let’s Talk About COVID

News July 15, 2022

LLS Invests in Solutions to Advance Health Equity

More than $1.3 million awarded through new LLS Equity in Access Research Program

July 14, 2022

Manuales

News July 12, 2022

How One Powerful Philanthropic Competition is Taking the Fight Against Cancer by Storm

Research July 7, 2022

Yescarta® Receives U.S. FDA Approval as First CAR T-cell Therapy for Initial Treatment of Relapsed or Refractory Large B-cell Lymphoma (LBCL)

SANTA MONICA, Calif. April 1, 2022 - Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) has approved Y…